Skip to main content
. 2022 Sep 21;12:137–146. doi: 10.1016/j.xjon.2022.08.014

Table 2.

Procedural outcomes

Parameter Value
Epicardial surgical time, h, mean ± SD 2.3 ± .6
Hospital length of stay following surgery, d, mean ± SD 3.03 ± 1.10
Endocardial catheter time, h, mean ± SD 2.1 ± 1.0
Time between first and second stages, d, mean ± SD 58.7 ± 45.3
Patients with complete PVI after first stage, n (%) 35 (88)
Patients with complete PVI after second stage, n (%) 40 (100)
Patients with complete left atrial “box” after first stage, n (%) 26 (65)
Patients with complete left atrial “box” after second stage, n (%) 38 (95)
Pacemaker implantation, n (%) 3 (8)
Off oral anticoagulation at last follow-up, n (%) 23 (68)
Off AADs at last follow-up, n (%) 28 (82)
Deaths within 30 d, n 0
TIA/stroke within 30 d, n 0
Phrenic nerve palsy, n (%) 1 (3)
Post-HA echocardiography findings, mean ± SD
 Time between pre-HA and post-HA echocardiography, y 3.0 ± 1.5
 Time between HA and post-HA echocardiography, y 2.8 ± 1.5
 LVEF, % 46.5 ± 12.8
 Left atrial size, cm 4.8 ± 1.0
Rhythm success (<30 s AF/AFL/AT; off AAD)
 Time between pre-HA and post-HA rhythm monitoring, y, mean ± SD 3.5 ± 1.9
 At 1 y, n (%) 26 (65)
 At 2 y, n (%) 25 (71)
 At 3 y, n (%) 15 (63)§

SD, Standard deviation; PVI, pulmonary vein isolation; AADs, antiarrhythmic drugs; TIA, transient ischemic attack; HA, hybrid ablation; LVEF, left ventricular ejection fraction; AF, atrial fibrillation; AFL, atrial flutter; AT, atrial tachycardia.

Out of 34 patients.

Out of 40 patients.

Out of 35 patients.

§

Out of 24 patients.